2.08
+0.01(+0.48%)
Currency In USD
| Previous Close | 2.07 |
| Open | 2.11 |
| Day High | 2.11 |
| Day Low | 2.08 |
| 52-Week High | 4.18 |
| 52-Week Low | 1.77 |
| Volume | 8,268 |
| Average Volume | 54,719 |
| Market Cap | 7.65M |
| PE | -0.95 |
| EPS | -2.19 |
| Moving Average 50 Days | 2.13 |
| Moving Average 200 Days | 2.59 |
| Change | 0.01 |
If you invested $1000 in Kiora Pharmaceuticals, Inc. (KPRX) 10 years ago, it would be worth $0.15 as of February 15, 2026 at a share price of $2.08. Whereas If you bought $1000 worth of Kiora Pharmaceuticals, Inc. (KPRX) shares 5 years ago, it would be worth $0.81 as of February 15, 2026 at a share price of $2.08.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Retinal Disease Expert Dr. Taiji Sakamoto Joins Kiora Pharmaceuticals' Scientific Advisory Board
Newsfile
Jan 27, 2026 12:00 PM GMT
Encinitas, California--(Newsfile Corp. - January 27, 2026) - Kiora Pharmaceuticals (NASDAQ: KPRX) has appointed leading retina specialist, Dr. Taiji Sakamoto, an expert in the treatment of retinal disease, to its Scientific Advisory Board. As an advi
Kiora Pharmaceuticals Granted U.S. Patent Covering Additional Formulations for the KIO-100 Family of Anti-Inflammatory Compounds
Newsfile
Dec 01, 2025 11:45 AM GMT
Encinitas, California--(Newsfile Corp. - December 1, 2025) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) today announced that the U.S. Patent and Trademark Office issued a new patent (US-12,472,263) on additional and novel formulations of the KIO-100
Kiora Pharmaceuticals to Participate in the 2025 Maxim Growth Summit and Eyecelerator @ AAO 2025
Newsfile
Oct 15, 2025 11:00 AM GMT
Encinitas, California--(Newsfile Corp. - October 15, 2025) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) today announced that it will participate in an ophthalmology panel at the upcoming 2025 Maxim Growth Summit in New York and give an overview of it